Perfil
Dan Parry is currently the Chief Financial Officer at Hydrexia Pty Ltd. Prior to this, he was the Chief Financial & Operating Officer at Oventus Medical Ltd. from 2017 to 2021.
Before that, he worked as the Chief Financial Officer & Secretary at Implicit Bioscience Ltd. from 2005 to 2013.
Mr. Parry holds an MBA from Kellogg School of Management.
Cargos activos de Dan Parry
| Empresas | Cargo | Inicio |
|---|---|---|
Hydrexia Pty Ltd.
Hydrexia Pty Ltd. Information Technology ServicesTechnology Services Provides hydrogen energy technology solutions | Director Financiero/CFO | 01/09/2013 |
Antiguos cargos conocidos de Dan Parry.
| Empresas | Cargo | Fin |
|---|---|---|
| OVES MEDI | Director Financiero/CFO | 04/06/2021 |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Director Financiero/CFO | 01/01/2013 |
Formación de Dan Parry.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Hydrexia Pty Ltd.
Hydrexia Pty Ltd. Information Technology ServicesTechnology Services Provides hydrogen energy technology solutions | Technology Services |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oventus Medical Ltd.
Oventus Medical Ltd. Medical SpecialtiesHealth Technology Develops oral appliances for the treatment of obstructive sleep disordered and snoring | Health Technology |
- Bolsa de valores
- Insiders
- Dan Parry
















